Stay updated on CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial
Sign up to get notified when there's something new on the CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial page.

Latest updates to the CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study history adds Contacts/Locations and Study Status sections to the record, updating how to reach the study team and showing the current recruitment status; a new revision (v3.6.4) was released.SummaryDifference0.5%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe study history gained a new revision entry (v3.6.3), replacing the previous v3.6.2, signaling an administrative update to the page's version history.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry v3.6.2 was added to the record history, and the previous revision v3.6.0 was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedKey sections such as Contacts/Locations, Study Status, Eligibility, Outcome Measures, and Arms/Interventions appear to be removed from the study record's version history UI, affecting access to core trial information and its status history.SummaryDifference10%

- Check58 days agoChange DetectedThe page adds quick access to 'Check who can join' and 'Find Contact Information', indicating new user interface options. The study record history updates with a new revision 'v3.6.0' and removes the previous 'v3.5.5' entry.SummaryDifference0.5%

- Check65 days agoChange DetectedAdds a new revision label (v3.5.5) and removes the previous label (v3.5.4) from the study record history, signaling an updated page revision is now available.SummaryDifference0.1%

Stay in the know with updates to CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial page.